Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid

    • Product Name L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid
    • Alias THIQ-3-COOH
    • Einecs 631-003-6
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    689849

    Chemical Name L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid
    Molecular Formula C10H11NO2
    Molecular Weight 177.20 g/mol
    Cas Number 942-36-7
    Appearance White to off-white powder
    Melting Point 235-240°C (dec.)
    Solubility Soluble in water and polar organic solvents
    Optical Rotation [α]20/D +36° (c=1, H2O)
    Purity Typically ≥98%
    Storage Temperature 2-8°C
    Synonyms L-THIQ-3-COOH; L-Tetrahydroisoquinoline-3-carboxylic acid
    Inchi Key GYMYBEEIPARJFR-JTQLQIEISA-N

    As an accredited L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The 25g L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid arrives in a sealed, labeled amber glass bottle with hazard warnings.
    Shipping L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid is shipped in sealed, chemically resistant containers to prevent contamination and moisture exposure. The packaging adheres to international regulations for safe transport of chemicals, including labelling with hazard information if needed. It is shipped at ambient temperature unless otherwise specified by the material safety data sheet (MSDS).
    Storage L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Store at 2-8°C (refrigerated). Avoid exposure to strong oxidizing agents, acids, or bases. Ensure appropriate labeling and restrict access to trained personnel only. Use personal protective equipment when handling.
    Application of L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid

    Applications of L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid in Industrial Manufacturing

    As a direct manufacturer specializing in L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid, we supply this advanced building block to established downstream industries supported by validated commercial and regulatory applications. Below, we highlight specific application channels, describing relevant compliance standards, recommended usage ranges in formulation, integration into downstream processes, and typical product types delivered by end users.

    1. Chiral Intermediate for Pharmaceutical Active Ingredient Synthesis

    This compound serves as a specialized chiral intermediate in the synthesis of certain isoquinoline alkaloid-based APIs, particularly in large-scale production lines for orphan and niche oncology therapeutics. Its stereochemistry enables precise control during the enantioselective steps of targeted molecule construction, directly impacting yield and purity in cGMP-compliant manufacturing environments.

    Industry compliance standards

    • ICH Q7 cGMP for APIs
    • EU GMP Part II
    • USP-NF monographs where applicable
    • EDQM Certification of Suitability (CEP) for API intermediates

    Typical usage ratio

    • Ranges from 1.5% to 4% of total API precursor mass, adjusted per target molecule structure and synthetic pathway; adjusted based on desired enantiomeric excess and batch size.

    Downstream process integration

    • Introduced at the asymmetric cyclization or reductive amination stage following initial substrate activation, usually under nitrogen-protected environments in glass-lined reactors to maintain enantiomeric purity.

    Final product types

    • Anticancer small molecule APIs (e.g., tetrahydroisoquinoline-based kinase inhibitors)
    • Rare disease pharmaceuticals in late-stage clinical and commercial production
    • Diagnostic imaging agents requiring high-purity chiral isoquinoline derivatives

    2. Key Component in Peptidomimetic Drug Development

    This carboxylic acid derivative is frequently used within peptidomimetic design to introduce conformational rigidity and metabolic stability into synthetic peptide analogues. Deployment in solid-phase peptide synthesis (SPPS) or solution-phase assembly supports the creation of structurally defined cyclic peptides and peptidomimetics with enhanced bioavailability and target affinity.

    Industry compliance standards

    • FDA 21 CFR Part 211 (Finished Pharmaceuticals)
    • WHO TRS 986 Annex 2 (GMP for APIs)
    • Japanese Pharmaceutical Excipients (JPE) reference if exported to Japan
    • EudraLex Volume 4 (Human and Veterinary Medicinal Products)

    Typical usage ratio

    • Typically 0.2–1 equivalent per peptide chain, defined by specific amino acid sequence and desired cyclization or branching position; excess is minimized to reduce post-synthesis purification load.

    Downstream process integration

    • Incorporated during primary peptide chain elongation or as a cyclization agent during peptide backbone modification step, utilizing automated peptide synthesizers in controlled cleanroom environments.

    Final product types

    • Cyclic peptide drug candidates
    • Metabolically stabilized bioactive peptides for chronic disease
    • Research-grade peptide standards for pharmaceutical R&D

    3. Fine Chemical Intermediate for Agrochemical Development

    Downstream agrochemical and crop protection companies use this raw material for elaborating novel heterocyclic scaffolds found in selective herbicides and proprietary insecticide compounds. Its compatibility with various nucleophilic aromatic substitution or cyclization reactions supports formulation of new actives with improved rainfastness and soil stability.

    Industry compliance standards

    • FAO/WHO JMPR Guidelines
    • OECD Good Laboratory Practice (GLP) for Test of Chemicals
    • REACH Annex VII Registration (where required)
    • ISO 9001:2015 for production and quality management

    Typical usage ratio

    • Routinely incorporated at 0.8%–3% of final formulation mass, modulated according to scaffold modification pathway and desired downstream biological activity.

    Downstream process integration

    • Added during early-stage ring construction or heterocycle elaboration under batch or continuous flow conditions; monitored via in-process HPLC and NMR for identity and purity assurance.

    Final product types

    • Selective herbicide technical concentrates
    • API-grade intermediates for crop protection “new mode of action” products
    • Custom agricultural research compounds

    4. Precursor for Specialty Polymer Synthesis

    This building block enables formation of advanced polyimide or polyamide materials with tailored flexibility and specific dielectric or mechanical profiles. Polymer manufacturers integrating this monomer gain access to new material grades for high-temperature electrical insulation and chemically resistant membranes used across electronics and process industries.

    Industry compliance standards

    • UL 94 (Flammability of Plastic Materials for Parts in Devices and Appliances)
    • IEC 60216 (Electrical Insulating Materials—Thermal Endurance)
    • ISO 14001 (Environmental Management in Polymer Production)
    • RoHS Directive 2011/65/EU (Restriction of Hazardous Substances)

    Typical usage ratio

    • Incorporated at 3–10 mol% relative to total dicarboxylic acid content; precise proportion tailored based on desired polymer chain length and mechanical characteristics of the end-use product.

    Downstream process integration

    • Directly dosed into polycondensation reactors where it reacts with diamines or alternative co-monomers under heat and vacuum to form high molecular weight polymers, followed by extrusion, casting, or injection molding as required.

    Final product types

    • High-performance electrical insulation films
    • Flexible printed circuit board substrates
    • Chemical-resistant membrane sheets
    Free Quote

    Competitive L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid: Direct From the Manufacturer’s Perspective

    Introduction to L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid

    Every batch of L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid reflects the skill, effort, and consistency that go into precision chemical manufacturing. The model under discussion carries a CAS number trusted in biochemical circles, with purity standards measured in the fraction of a percentage and a well-established profile in pharmaceutical synthesis. Our process focuses on minimizing moisture, controlling particle size, and ensuring end-to-end traceability from raw materials straight through to finished container.

    This compound features prominently in projects centered around chiral intermediates, enzyme substrates, and advanced pharmaceutical ingredients. Typical chemical formula stays consistent, but slight variations in crystalline habit or trace impurity levels can trigger major changes in reactivity if care is not taken at each step. Reliability comes from practice and a thorough understanding of how changes in temperature, pH, or solvent conditions shape the finished acid.

    Manufacturing Experience: Consistency Through Process Control

    Early on, batches were made at lab scale in glassware, leading to unexpected by-products and yield issues. Scale-up demanded refinements: reactor temperature surveys, much tighter solvent specifications, and routine filtration checks. By tracking impurity signatures batch-by-batch, we learned which steps called for extra drying, which called for patience to avoid over-reaction.

    Crystal form plays a decisive role in the end-application. We train our staff to detect shifts in powder texture and color, signs of a process drifting off target. Each finished drum undergoes FTIR confirmation, along with HPLC calibration to verify both yield and purity. Rules for handling solvents, acids, and bases get briefed every shift. The staff isn’t just following protocols; they know why a sloppy neutralization step could foul the product with hard-to-remove salts.

    Specifications Shaped by Real-World Demands

    Buyers come with their own standards and applications in mind, most focus tightly on purity levels, residual solvent content, and trace metals in the finished acid. Over years of repeated synthesis, a typical specification took shape: crystalline solid, white to off-white, moisture content held below 0.5%, and purity measured to four decimal places. We maintain flexibility—request volumes from grams to hundreds of kilos arrive regularly, and tighter impurity specs show up as customers’ needs evolve.

    Many in the industry know what happens if you slack off on spectral analysis or trust “good enough” instead of confirmed metrics. One customer, developing an enzyme inhibitor, saw their project grind to a halt until we traced a minor impurity back to a forgotten filter pad swap. The lab reran the purification, repeated the analysis, and delivered a solution. These moments drive process improvement long after the material leaves our gates.

    Usage in Industry: From Lab Bench to Plant Scale

    Most demand springs from pharmaceutical companies, where every impurity needs accounting, or from research groups constructing new heterocyclic frameworks. The acid group at position 3 on the tetrahydroisoquinoline core turns this molecule into a versatile building block for peptide mimics, beta-lactam precursors, or custom ligands. In the hands of a capable synthetic chemist, our material supports recombinant enzyme studies or routes to alkaloid analogues.

    Production runs shift volume frequently. Institutes running small pilot trials request 100-gram lots, while pharmaceutical facilities order hundreds of kilos at a time. Each scale requires careful control to avoid cross-contamination. We clean reactors, glassware, and tools with dedicated regimens before running each batch. Shelf-life and storage cannot be overlooked, with light, moisture, and airborne particles screened out daily in climate-controlled warehouses.

    Differences from Other Tetrahydroisoquinoline Compounds

    Not all isoquinoline derivatives show the exact characteristics critical for precise synthesis. The position of the carboxylic acid, the configuration of chiral centers, and the nature of the ring saturation affect everything from chemical reactivity to compatibility with downstream catalysts. Some customers approach us after realizing generic tetrahydroisoquinolines—often bulk sourced—contain unwanted homologs or by-products, which can disrupt downstream synthesis later.

    For example, the L-configuration in our product guarantees consistent stereochemistry, translating to predictable biological activity in use. D-isomers often exist as contaminants in less rigorously controlled sources. Customers relying on hydrogenated variants or unsubstituted isoquinolines may not get the same results, since substituent effects on the aromatic system strongly influence binding affinity in target proteins.

    Batch uniformity sets our product apart as well. Each lot passes thorough chiral HPLC to verify enantiomeric excess, helping chemists avoid complications in optical purity. Some alternative products lack this critical documentation, and their lots may shift in chiral composition over time. Ultimately, researchers trust manufacturer-originated product because the full history of each batch is available upon request—a story stretching from raw material drum through final packaging.

    Meeting Customer Needs: A Manufacturer’s Role

    Requests come in with a wide variety of applications in mind—from pilot-scale route design to full GMP-active pharmaceutical production. Our technical team stays closely involved in scale-ups, offering insight on practical reaction conditions, process hygiene, and intermediate handling. On occasion, a customer will run into issues with solubility, reaction selectivity, or product crystal form. Quick response from the manufacturing end, rooted in hands-on process familiarity, often makes the difference between success and costly waste.

    Rarely a month passes without a customer requesting a modification: different solvent system, stricter impurity cap, or fresh batch re-certified for a time-sensitive campaign. These tweaks flow directly from production to QC and then to shipping under our documented change control policy. Experience tells us that neglecting these details at the manufacturing end often magnifies headaches for the user downstream.

    Keeping up with documentation sets a high bar. Each shipment leaves with a thorough certificate of analysis, signed batch records, and full data on process and purity. This effort simplifies regulatory review and, most importantly, gives researchers the confidence that every sample meets the claims on its label.

    Process Improvements Driven by Experience

    Continuous improvement runs through every aspect of manufacturing this compound. Process chemists monitor trends from small sampling failures in the lab all the way to full production batches. We maintain a feedback loop with customers, picking up reports of odd solubility, yield loss, or color drift, and swiftly trace them back to changes in solvents, timing, or purification steps. A spike in moisture content last year, traced to a single leaky reactor gasket, prompted an overhaul of preventive maintenance schedules throughout the plant.

    Employee experience keeps issues visible as they form. Operators responsible for crystallization become adept at spotting shifts in texture or luster that point toward off-spec contaminants. Changes in regulatory requirements—especially with pharmaceutical customers—trigger upgrades in both instrumentation and documentation. We see every compliance audit as a chance to stress-test our system; deficiencies spark immediate improvement plans rather than paperwork pushback.

    Supporting the Science: Knowledge, Not Just Product

    As chemical manufacturers, our role stretches beyond filling orders. Application support sits alongside product quality in importance. Frequently, researchers come to us seeking data on solvent compatibility, stability in peptide-coupling conditions, or behavior in nonaqueous chromatographic separation. Responses draw on hands-on experience with the acid, collected over dozens of campaigns, rather than rote answers.

    Pattern recognition—knowing that certain temperature ramps cause anomalous impurity spikes or that some plastic containers can interact with the product—grows from time spent handling the compound directly. In our work, this knowledge gets passed along in every technical call or troubleshooting document, building trust with the scientific community we support.

    Challenges and Solutions in Manufacturing

    Every year seems to bring new hurdles: raw material delays, shifts in purity standards, competition from less regulated markets. We meet these by sticking to proven protocols, doubling down on supplier audits, and training each new staff member in hands-on, detail-oriented method. The margin for error in chiral intermediates is thin. Skipping a verification step can trigger long delays for customers, regulatory headaches, or in the worst cases, wasted investment in large-scale synthesis.

    Improvement efforts rarely focus on one process change at a time. Instead, process teams balance modifications in filtration, solvent recycling, and final drying routines to sharpen purity and suppress off-spec batches. Investments in analytic equipment—high-resolution LC-MS, chiral HPLC, and Karl Fischer water testing—aid in both process control and batch release. Feedback from QC to the plant floor is rapid; issues in one batch become part of training for the next, ensuring errors do not recur.

    Why Source Directly from the Manufacturer?

    Our customers often share stories of slow lead times, unreliable paperwork, or lackluster support from intermediaries. Direct communication, deep process knowledge, and quick adaptation form our strongest attributes as a manufacturer. Every gram gets tracked from drum to package under a unified quality system.

    Off-the-shelf traders or overseas consolidators might offer lower prices. These sources often lack the detailed batch histories, in-process monitoring data, and application insights needed for sensitive projects. Secure packaging, careful shipment conditions, and full compliance with international transport standards help prevent costly delays or regulatory issues at delivery.

    Our documentation and process transparency enable us to support auditing, regulatory submissions, and rapid troubleshooting. Direct engagement lets research teams or scale-up managers clarify needs in real time, cutting down trial-and-error and boosting project success rates in the long run.

    Future of L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid Manufacturing

    Markets change fast: a blockbuster drug launch in Asia can swing global demand in weeks, while stricter impurity thresholds ripple through specifications by the end of the quarter. We keep pace through constant monitoring of trends, maintaining close communication with customers, and steady investment in both people and process upgrades.

    Emerging synthetic pathways, calls for greener chemistry, and demand for absolute traceability challenge established habits. We track solvent recovery, examine environmental impact, and push for lower-waste solutions in every campaign. Feedback from research groups helps us improve our scheduling and batch optimization to support both speed and quality.

    Newer fields, such as radiolabelled synthesis or advanced catalyst design, draw on the same foundations: clean, reproducible, fully-verified starting materials. By continually tightening our control and feeding new knowledge into the production line, we keep ourselves and our customers ahead of the curve.

    Summary: More Than a Compound

    Producing L-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid isn’t just a technical challenge—it reflects a broader commitment to quality, reliability, and open communication. From sampling through packaging, every step draws on established experience and a drive to continuously improve.

    Years spent refining process, documenting outcomes, educating new hires, and responding to customer needs shape the product as much as the raw materials themselves. Our direct involvement in each phase means that behind every drum stands a real team, invested in your project’s outcome and willing to answer the technical questions that make a difference between theory and result.

    From where we work, quality starts far before the first batch and continues through every order. The best results flow from direct manufacturer collaboration, persistent attention to detail, and a willingness to learn from each success—and each mistake.